0001708138-21-000086.txt : 20211117 0001708138-21-000086.hdr.sgml : 20211117 20211117160448 ACCESSION NUMBER: 0001708138-21-000086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211115 FILED AS OF DATE: 20211117 DATE AS OF CHANGE: 20211117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURPHY ANDREW J CENTRAL INDEX KEY: 0001796226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211420618 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-11-15 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001796226 MURPHY ANDREW J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Research Common Stock 2021-08-16 5 G 0 1645 0.0 D 55705 D Common Stock 2021-11-15 4 M 0 16579 52.03 A 72284 D Common Stock 2021-11-15 4 F 0 9412 641.5 D 62872 D Common Stock 2021-11-16 4 S 0 465 642.76 D 62407 D Common Stock 2021-11-16 4 S 0 924 643.42 D 61483 D Common Stock 2021-11-16 4 S 0 1106 644.71 D 60377 D Common Stock 2021-11-16 4 S 0 1640 645.41 D 58737 D Common Stock 2021-11-16 4 S 0 557 646.52 D 58180 D Common Stock 2021-11-16 4 S 0 844 647.39 D 57336 D Common Stock 2021-11-16 4 S 0 86 648.2 D 57250 D Common Stock 2021-11-16 4 S 0 5 649.26 D 57245 D Common Stock 2021-11-16 4 S 0 296 651.42 D 56949 D Common Stock 2021-11-16 4 S 0 133 652.24 D 56816 D Common Stock 2021-11-16 4 S 0 454 653.31 D 56362 D Common Stock 2021-11-16 4 S 0 198 654.34 D 56164 D Common Stock 2021-11-16 4 S 0 92 655.3 D 56072 D Common Stock 2021-11-16 4 S 0 74 657.46 D 55998 D Common Stock 2021-11-16 4 S 0 71 658.56 D 55927 D Common Stock 2021-11-16 4 S 0 155 659.15 D 55772 D Common Stock 2021-11-16 4 S 0 67 660.32 D 55705 D Common Stock 4269 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 52.03 2021-11-15 4 M 0 16579 0.0 D 2021-12-16 Common Stock 16579 16500 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 465 shares of Company stock on November 16, 2021 at prices ranging from $642.35 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 924 shares of Company stock on November 16, 2021 at prices ranging from $643.07 to $643.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 1,106 shares of Company stock on November 16, 2021 at prices ranging from $644.24 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 1,640 shares of Company stock on November 16, 2021 at prices ranging from $645.01 to $645.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 557 shares of Company stock on November 16, 2021 at prices ranging from $646.12 to $646.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 844 shares of Company stock on November 16, 2021 at prices ranging from $647.09 to $647.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 86 shares of Company stock on November 16, 2021 at prices ranging from $648.15 to $648.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 296 shares of Company stock on November 16, 2021 at prices ranging from $651.00 to $651.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 133 shares of Company stock on November 16, 2021 at prices ranging from $652.22 to $652.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 454 shares of Company stock on November 16, 2021 at prices ranging from $653.04 to $653.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 198 shares of Company stock on November 16, 2021 at prices ranging from $654.07 to $654.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 92 shares of Company stock on November 16, 2021 at prices ranging from $655.20 to $655.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. Represents volume-weighted average price of sales of 155 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Andrew Murphy 2021-11-17